-+ 0.00%
-+ 0.00%
-+ 0.00%

Cormedix Raises FY2026 Sales Guidance from $300.000M-$320.000M to $325.000M-$345.000M vs $308.224M Est

Benzinga·05/14/2026 13:28:01
Listen to the news
Cormedix (NASDAQ:CRMD) raises FY2026 sales outlook from $300.000 million-$320.000 million to $325.000 million-$345.000 million vs $308.224 million estimate.